Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Background The sentinel lymph node (SLN) is the first lymph node to receive the lymphatic drainage of a primary tumour; based on the knowledge that CK19 is positive in more than 95% of breast carcinomas, a molecular method for intraoperative diagnosis of SLN metastases (the one-step nucleic acid amplification (OSNA) assay) was developed. Aims To evaluate CK19 immunoreactivity in a series of special histological types of breast carcinoma in order to verify whether the OSNA assay can be used in all breast cancer cases independently of the histological type. Methods 116 samples of invasive breast carcinomas of special...
Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymph nod...
The one-step nucleic acid amplification (OSNA) assay is a molecular method used for detecting breast...
International audienceBackground - In head and neck squamous cell carcinoma (HNSCC) 30% of cN0 patie...
The one-step nucleic acid amplification (OSNA) method is an increasingly used procedure for intraope...
Analysis of sentinel lymph nodes (SLNs) by means of One-Step Nucleic Acid Amplification (OSNA) is ga...
Staging by sentinel node (SN) biopsy is the standard procedure for clinically node-negative breast c...
BACKGROUND: Intraoperative analysis of lymph nodes during a sentinel lymph node biopsy (SLNB) proced...
A maioria dos carcinomas invasivos da mama são classificados como carcinoma ductal invasivo, sem out...
ABSTRACT Sentinel lymph node (SLN) is defined as the first of a few selected lymphatic nodes, into w...
One-step nucleic acid amplification (OSNA) detects and quantifies, with the use of a polymerase chai...
Introduction: The one-step nucleic acid amplification (OSNA) assay is a new method to detect sentin...
Breast carcinoma is the major cause of cancer-related death in women. The incidence of this carcinom...
One-step nucleic acid amplification (OSNA) is a rapid intraoperative molecular detection technique f...
Aims Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymp...
International audienceOne-step nucleic acid amplification (OSNA, Sysmex, Kobe, Japan) offers an exce...
Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymph nod...
The one-step nucleic acid amplification (OSNA) assay is a molecular method used for detecting breast...
International audienceBackground - In head and neck squamous cell carcinoma (HNSCC) 30% of cN0 patie...
The one-step nucleic acid amplification (OSNA) method is an increasingly used procedure for intraope...
Analysis of sentinel lymph nodes (SLNs) by means of One-Step Nucleic Acid Amplification (OSNA) is ga...
Staging by sentinel node (SN) biopsy is the standard procedure for clinically node-negative breast c...
BACKGROUND: Intraoperative analysis of lymph nodes during a sentinel lymph node biopsy (SLNB) proced...
A maioria dos carcinomas invasivos da mama são classificados como carcinoma ductal invasivo, sem out...
ABSTRACT Sentinel lymph node (SLN) is defined as the first of a few selected lymphatic nodes, into w...
One-step nucleic acid amplification (OSNA) detects and quantifies, with the use of a polymerase chai...
Introduction: The one-step nucleic acid amplification (OSNA) assay is a new method to detect sentin...
Breast carcinoma is the major cause of cancer-related death in women. The incidence of this carcinom...
One-step nucleic acid amplification (OSNA) is a rapid intraoperative molecular detection technique f...
Aims Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymp...
International audienceOne-step nucleic acid amplification (OSNA, Sysmex, Kobe, Japan) offers an exce...
Cytokeratin 19 (CK19) mRNA copy number predicts the probability of tumour load in axillary lymph nod...
The one-step nucleic acid amplification (OSNA) assay is a molecular method used for detecting breast...
International audienceBackground - In head and neck squamous cell carcinoma (HNSCC) 30% of cN0 patie...